We are live on ! Find out more
MTNB icon

Matinas BioPharma

62 hedge funds and large institutions have $36.7M invested in Matinas BioPharma in 2020 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 12

3% less funds holding

Funds holding: 64 → 62 (-2)

3.15% less ownership

Funds ownership: 27.18% → 24.03% (-3.2%)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

66% less capital inflows, than outflows

Capital inflows: $2.38M | Capital outflows: $6.9M

Holders
62
Holders Change
-2
Holders Change %
-3.13%
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
16
Reduced
12
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

MTNB Hedge Fund Activity: Q2 2020 in Review

62 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q2 2020, worth a combined $36.7M — up 14% from $32M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of MTNB and 8 opened new positions — a net loss of 3 holders — while 12 trimmed existing stakes and 16 added.

The largest buyer was Two Sigma Investments, adding an estimated $467K. The largest seller was Victory Capital Management, cutting an estimated $2.05M.

  • 62 institutional investors held Matinas BioPharma (MTNB) as of Q2 2020, down from 64 in Q1 2020.
  • Funds reported $36.7M of Matinas BioPharma stock for Q2 2020, up 14% quarter-over-quarter.
  • 8 funds opened new Matinas BioPharma positions in Q2 2020 and 11 closed out, a net change of -3 holders.
  • The largest Matinas BioPharma buyer in Q2 2020 was Two Sigma Investments, an estimated $467K added.
  • The largest Matinas BioPharma seller in Q2 2020 was Victory Capital Management, an estimated $2.05M sold.

Based on aggregated 13F filings for Q2 2020.